Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blake Roessler

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|January 17, 2004
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vectorAlicia Terando, Blake Roessler, James J Mulé
IISE Transactions|October 12, 2020
Access Planning and Resource Coordination for Clinical Research OperationsJivan Deglise-Hawkinson, David L Kaufman, Blake Roessler, et al.
The Journal of Gene Medicine|November 30, 2006
Restituting intestinal epithelial cells exhibit increased transducibility by adenoviral vectorsFilippos Kesisoglou, Phyllissa Schmiedlin-Ren, David Fleisher, et al.
Arthritis Research|May 16, 2002
Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatantJianmin Yang, Michael S Friedman, Huimin Bian, et al.
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanomaBruce G Redman, Alfred E Chang, Joel Whitfield, et al.
Inflammatory Bowel Diseases|May 4, 2005
Increased transduction of human intestinal epithelial cells by adenoviral vectors in inflammatory bowel diseasePhyllissa Schmiedlin-Ren, Filippos Kesisoglou, John A Mapili, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|January 17, 2004
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vectorAlicia Terando, Blake Roessler, James J Mulé
IISE Transactions|October 12, 2020
Access Planning and Resource Coordination for Clinical Research OperationsJivan Deglise-Hawkinson, David L Kaufman, Blake Roessler, et al.
The Journal of Gene Medicine|November 30, 2006
Restituting intestinal epithelial cells exhibit increased transducibility by adenoviral vectorsFilippos Kesisoglou, Phyllissa Schmiedlin-Ren, David Fleisher, et al.
Arthritis Research|May 16, 2002
Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatantJianmin Yang, Michael S Friedman, Huimin Bian, et al.
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanomaBruce G Redman, Alfred E Chang, Joel Whitfield, et al.
Inflammatory Bowel Diseases|May 4, 2005
Increased transduction of human intestinal epithelial cells by adenoviral vectors in inflammatory bowel diseasePhyllissa Schmiedlin-Ren, Filippos Kesisoglou, John A Mapili, et al.
Pageof 1